Drug comparisons
Insulin Regular Human vs Alogliptin
Regular insulin vs alogliptin: short-acting injectable human insulin for meals vs oral DPP-4 inhibitor (Nesina) for type 2 diabetes glycemic control.
No comparison dimensions are available for this page.
Clinical context
Type 2 diabetes patients comparing oral DPP-4 inhibitor therapy to injectable regular insulin for glycemic management.
Bottom line
Regular insulin and alogliptin serve distinct roles, with alogliptin as an oral option primarily for type 2 diabetes.
All medication comparisons